Pharma Mar SA
OTC:PHMMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Pharma Mar SA (PHMMF) under the Base Case is USD per share.
Compared with the current market price of 75.05 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Pharma Mar Does
Pharma Mar is a Spanish biopharmaceutical company focused on cancer drugs. It discovers and develops medicines from marine organisms, then turns the best candidates into prescription treatments for hard-to-treat tumors. Its best-known products include oncology drugs sold directly or through partners in different markets.
- Headquarters
- Spain ES
- Employees
- 505
- IPO date
- Nov 2, 2015
Revenue & Expenses Breakdown
Pharma Mar SA
Earnings Waterfall
Pharma Mar SA
What is the Intrinsic Value of one PHMMF stock?
The intrinsic value for Pharma Mar SA (PHMMF) under the Base Case is USD.
Is PHMMF stock undervalued or overvalued?
Compared with the current market price of 75.05 USD, the stock appears .
